![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/25/2903924/0/en/BlueSphere-Bio-To-Partner-with-NMDP-BioTherapies-for-the-Company-s-First-In-Human-TCR-based-Product-Candidate-in-Combination-with-Allogeneic-Hematopoietic-Cell-Transplantation-Tria.html
https://www.globenewswire.com/news-release/2024/06/04/2893172/0/en/BlueSphere-Bio-Establishes-Strategic-Collaboration-with-the-National-Cancer-Institute-to-Advance-Treatments-for-Rare-Respiratory-Disease.html
https://www.globenewswire.com/news-release/2024/06/03/2892552/0/en/BlueSphere-Bio-Announces-IND-Clearance-of-its-First-in-Human-Candidate-and-New-Cell-Therapy-Portfolio-for-High-Risk-Leukemia-Patients.html
https://www.globenewswire.com/news-release/2024/05/30/2890893/0/en/BlueSphere-Bio-to-Present-Corporate-Update-and-Participate-in-a-Panel-Discussion-at-the-2024-BIO-International-Convention.html
https://www.globenewswire.com/news-release/2023/03/01/2618429/0/en/BlueSphere-Bio-to-Present-at-the-Next-Generation-CAR-T-Cell-Therapies-Conference.html
https://www.globenewswire.com/news-release/2023/02/06/2602270/0/en/BlueSphere-Bio-to-Present-at-the-25th-Annual-BIO-CEO-Investor-Conference.html
https://www.globenewswire.com/news-release/2023/01/30/2597753/0/en/BlueSphere-Bio-Appoints-Erkut-Bahceci-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2022/11/10/2553338/0/en/BlueSphere-Bio-Presents-Data-Demonstrating-the-Potential-of-Lead-Product-Candidate-at-37th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/11/03/2547960/0/en/BlueSphere-Bio-Data-to-be-Presented-at-the-37th-Society-for-Immunotherapy-of-Cancer-SITC-Annual-Meeting.html
https://www.globenewswire.com/news-release/2022/10/04/2528009/0/en/BlueSphere-Bio-Appoints-Keir-Loiacono-as-Chief-Executive-Officer.html